410 related articles for article (PubMed ID: 34767753)
1. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
Wang M; Earley M; Chen L; Hanson BM; Yu Y; Liu Z; Salcedo S; Cober E; Li L; Kanj SS; Gao H; Munita JM; Ordoñez K; Weston G; Satlin MJ; Valderrama-Beltrán SL; Marimuthu K; Stryjewski ME; Komarow L; Luterbach C; Marshall SH; Rudin SD; Manca C; Paterson DL; Reyes J; Villegas MV; Evans S; Hill C; Arias R; Baum K; Fries BC; Doi Y; Patel R; Kreiswirth BN; Bonomo RA; Chambers HF; Fowler VG; Arias CA; van Duin D;
Lancet Infect Dis; 2022 Mar; 22(3):401-412. PubMed ID: 34767753
[TBL] [Abstract][Full Text] [Related]
2. Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.
Cienfuegos-Gallet AV; Zhou Y; Ai W; Kreiswirth BN; Yu F; Chen L
Microbiol Spectr; 2022 Apr; 10(2):e0229021. PubMed ID: 35230130
[TBL] [Abstract][Full Text] [Related]
3. A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
Xiao T; Zhu Y; Zhang S; Wang Y; Shen P; Zhou Y; Yu X; Xiao Y
J Infect Dis; 2020 Mar; 221(Suppl 2):S174-S183. PubMed ID: 32176799
[TBL] [Abstract][Full Text] [Related]
4. Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae.
van Duin D; Cober E; Richter SS; Perez F; Kalayjian RC; Salata RA; Evans S; Fowler VG; Kaye KS; Bonomo RA
J Antimicrob Chemother; 2015 Apr; 70(4):1203-11. PubMed ID: 25492391
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.
Chang H; Wei J; Zhou W; Yan X; Cao X; Zuo L; Chen S; Yao K; Huang R; Chen Y; Wu C
J Infect Public Health; 2020 May; 13(5):784-790. PubMed ID: 31843651
[TBL] [Abstract][Full Text] [Related]
6. Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy.
Lee NY; Tsai CS; Syue LS; Chen PL; Li CW; Li MC; Ko WC
Clin Ther; 2020 Mar; 42(3):e33-e44. PubMed ID: 32061374
[TBL] [Abstract][Full Text] [Related]
7. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.
Li Y; Li J; Hu T; Hu J; Song N; Zhang Y; Chen Y
Antimicrob Resist Infect Control; 2020 Jun; 9(1):79. PubMed ID: 32487221
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of carbapenem-resistant
Wang Y; Lei H; Zhang Y; Yang Q; Wang Y; Wang J; Xu C; Yu J; Zhou L; Kang X; Cui L
Antimicrob Resist Infect Control; 2018; 7():66. PubMed ID: 29942492
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and survival of patients infected with carbapenem-resistant Klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study.
Cienfuegos-Gallet AV; Ocampo de Los Ríos AM; Sierra Viana P; Ramirez Brinez F; Restrepo Castro C; Roncancio Villamil G; Del Corral Londoño H; Jiménez JN
BMC Infect Dis; 2019 Oct; 19(1):830. PubMed ID: 31590648
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: A large multicentre case-control and cohort study.
Lou T; Du X; Zhang P; Shi Q; Han X; Lan P; Yan R; Hu H; Wang Y; Wu X; Jiang Y; Yu Y
J Infect; 2022 May; 84(5):637-647. PubMed ID: 35301013
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.
Zhang Y; Guo LY; Song WQ; Wang Y; Dong F; Liu G
BMC Infect Dis; 2018 May; 18(1):248. PubMed ID: 29855274
[TBL] [Abstract][Full Text] [Related]
12. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
Micozzi A; Gentile G; Minotti C; Cartoni C; Capria S; Ballarò D; Santilli S; Pacetti E; Grammatico S; Bucaneve G; Foà R
BMC Infect Dis; 2017 Mar; 17(1):203. PubMed ID: 28283020
[TBL] [Abstract][Full Text] [Related]
13. Colistin versus polymyxin B for the treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
Vieceli T; Henrique LR; Rech TH; Zavascki AP
J Infect Chemother; 2024 Jul; 30(7):621-625. PubMed ID: 38244722
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital.
Zhang N; Qi L; Liu X; Jin M; Jin Y; Yang X; Chen J; Qin S; Liu F; Tang Y; Jia R; Zhang X; Wang Y; Guo J; Liu J; Wang C; Chen Y
Microbiol Spectr; 2022 Oct; 10(5):e0169022. PubMed ID: 36190403
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of cefepime breakpoint in patients with carbapenem-resistant Klebsiella pneumoniae bacteraemia.
Lee NY; Lo CL; Chen PL; Syue LS; Li CW; Li MC; Ko WC
Int J Antimicrob Agents; 2021 Feb; 57(2):106250. PubMed ID: 33264671
[TBL] [Abstract][Full Text] [Related]
16. A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting.
Aslan AT; Kırbaş E; Sancak B; Tanrıverdi ES; Otlu B; Gürsoy NC; Yılmaz YA; Tozluyurt A; Liste Ü; Bıçakcıgil A; Hazırolan G; Dağ O; Güven GS; Akova M;
Int J Antimicrob Agents; 2022 Apr; 59(4):106554. PubMed ID: 35176476
[TBL] [Abstract][Full Text] [Related]
17. Spread of Carbapenem-Resistant Klebsiella pneumoniae in an Intensive Care Unit: A Whole-Genome Sequence-Based Prospective Observational Study.
Wei L; Wu L; Wen H; Feng Y; Zhu S; Liu Y; Tang L; Doughty E; van Schaik W; McNally A; Zong Z
Microbiol Spectr; 2021 Sep; 9(1):e0005821. PubMed ID: 34259540
[TBL] [Abstract][Full Text] [Related]
18. The Colonization of Carbapenem-Resistant Klebsiella pneumoniae: Epidemiology, Resistance Mechanisms, and Risk Factors in Patients Admitted to Intensive Care Units in China.
Qin X; Wu S; Hao M; Zhu J; Ding B; Yang Y; Xu X; Wang M; Yang F; Hu F
J Infect Dis; 2020 Mar; 221(Suppl 2):S206-S214. PubMed ID: 32176790
[TBL] [Abstract][Full Text] [Related]
19. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019.
Hsu JY; Chuang YC; Wang JT; Chen YC; Hsieh SM
J Formos Med Assoc; 2021 Nov; 120(11):1994-2002. PubMed ID: 33962811
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo-β-Lactamase-1.
Dong F; Zhang Y; Yao K; Lu J; Guo L; Lyu S; Yang Y; Wang Y; Zheng H; Song W; Liu G
Microb Drug Resist; 2018 Mar; 24(2):154-160. PubMed ID: 28594635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
